DE60127901T2 - TCF-1 Nukleotidsequenzvariation - Google Patents

TCF-1 Nukleotidsequenzvariation Download PDF

Info

Publication number
DE60127901T2
DE60127901T2 DE60127901T DE60127901T DE60127901T2 DE 60127901 T2 DE60127901 T2 DE 60127901T2 DE 60127901 T DE60127901 T DE 60127901T DE 60127901 T DE60127901 T DE 60127901T DE 60127901 T2 DE60127901 T2 DE 60127901T2
Authority
DE
Germany
Prior art keywords
allele
tcf
seq
alleles
genotype
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60127901T
Other languages
German (de)
English (en)
Other versions
DE60127901D1 (de
Inventor
Ann Bethea El Cerrito Begovich
Henry Anthony Oakland Erlich
Andrew Redwood City Gruppe
Janelle Annette Berkeley Noble
Gary Allen Redwood City Peltz
Rebecca Lynne Alameda Reynolds
Karen Myra Alameda Walker
Gabriele Zangenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of DE60127901D1 publication Critical patent/DE60127901D1/de
Publication of DE60127901T2 publication Critical patent/DE60127901T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60127901T 2000-07-21 2001-07-17 TCF-1 Nukleotidsequenzvariation Expired - Lifetime DE60127901T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21981200P 2000-07-21 2000-07-21
US219812 2000-07-21

Publications (2)

Publication Number Publication Date
DE60127901D1 DE60127901D1 (de) 2007-05-31
DE60127901T2 true DE60127901T2 (de) 2008-01-17

Family

ID=22820882

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60127901T Expired - Lifetime DE60127901T2 (de) 2000-07-21 2001-07-17 TCF-1 Nukleotidsequenzvariation

Country Status (6)

Country Link
US (2) US6656691B2 (https=)
EP (1) EP1174522B1 (https=)
JP (1) JP4846130B2 (https=)
AT (1) ATE360094T1 (https=)
DE (1) DE60127901T2 (https=)
ES (1) ES2286060T3 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100559182C (zh) 2003-08-29 2009-11-11 株式会社东芝 显色试剂、浓度测定试剂盒、浓度测定方法和在该方法中使用的传感器芯片
CN101031649A (zh) * 2004-10-01 2007-09-05 淡马锡生命科学研究院有限公司 水稻凝集素样受体激酶1(OsLRK1)，一个参与植物发育的基因
US20080268442A1 (en) * 2007-04-24 2008-10-30 Igd Intel, Llc Method and system for preparing a blood sample for a disease association gene transcript test
US8135545B2 (en) 2007-11-09 2012-03-13 Iverson Genetic Diagnostics, Inc. System and method for collecting data regarding broad-based neurotoxin-related gene mutation association
US20090125244A1 (en) * 2007-11-09 2009-05-14 Igd Intel Llc Broad-based neurotoxin-related gene mutation association from a gene transcript test

Also Published As

Publication number Publication date
EP1174522B1 (en) 2007-04-18
EP1174522A9 (en) 2002-07-03
EP1174522A2 (en) 2002-01-23
JP2002330755A (ja) 2002-11-19
US20030203395A1 (en) 2003-10-30
ATE360094T1 (de) 2007-05-15
EP1174522A3 (en) 2004-02-18
DE60127901D1 (de) 2007-05-31
ES2286060T3 (es) 2007-12-01
US6656691B2 (en) 2003-12-02
JP4846130B2 (ja) 2011-12-28
US20030054350A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
DE68926784T2 (de) Verfahren zur charakterisierung von hla dp
Iyengar et al. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration
DE69838984T2 (de) Risikoabschätzung für chronische atemwegserkrankungen und anwendungen
Flanigan et al. Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy
DE69616478T2 (de) Nachweis genetischer Prädisposition zu periodontalen Erkrankungen
DE69715669T2 (de) Detektion einer genetischen prädisposition für diabetische retinopathie mit dem risiko des verlusts der sehkraft
Fitness et al. Large-scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi.
Ahmed et al. Prenatal diagnosis of beta‐thalassaemia in Pakistan: experience in a Muslim country
DE69833856T2 (de) Verfahren zur bestimmung von nukleinsäuresequenzen in urin
DE69434314T2 (de) Polymorphismus von mononukleotiden und ihre verwendung in der genanalyse
DE69003477T2 (de) Verfahren zum Nachweis von Nucleinsäuren.
CN103710458A (zh) 预测抗tnf响应性或无响应性的生物标志物
Chiu et al. Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanning
DE69523586T2 (de) Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen
DE60026150T2 (de) Diagnostika und therapeutika für osteoporose
DE69230221T2 (de) Verfahren für die in-vitro-diagnose von mit charcot-marie-tooth-krankheit vom typ-1a zusammenhängenden chromosomenanomalien
DE69503885T2 (de) Gemeinschaftlich verwendete genetische marker zur diagnostik der alzheimerschen krankheit, methode und diagnostischer reagenziensatz
EP1730315B1 (de) Polymorphismen im nod2/card15 gen
DE69125368T2 (de) Karakterisierung von hla-dqbeta-dns
DE60128434T2 (de) Polymorphismen im menschlichen KDR Gene
DE60127901T2 (de) TCF-1 Nukleotidsequenzvariation
DE69506704T2 (de) Verfahren und proben zum nachweis von mit dem locus der infantilen spinalamyotrophien verbundenen markern
DE60036750T2 (de) Verfahren zur Abschätzung der Sensitivität für Osteoporose-Medikamente
DE60226244T2 (de) Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sind
DE602004009083T2 (de) Verwendung von humanen oatp-c polymorphismen, die einen effekt auf die pharmakokinetik von statin haben, bei der statin-therapie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition